DE20221247U1 - Transdermal-Pflaster zum Verabreichen von Fentanyl - Google Patents
Transdermal-Pflaster zum Verabreichen von Fentanyl Download PDFInfo
- Publication number
- DE20221247U1 DE20221247U1 DE20221247U DE20221247U DE20221247U1 DE 20221247 U1 DE20221247 U1 DE 20221247U1 DE 20221247 U DE20221247 U DE 20221247U DE 20221247 U DE20221247 U DE 20221247U DE 20221247 U1 DE20221247 U1 DE 20221247U1
- Authority
- DE
- Germany
- Prior art keywords
- backing layer
- disposed
- transdermal patch
- single phase
- polymeric composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE20221247U DE20221247U1 (de) | 2001-03-16 | 2002-03-15 | Transdermal-Pflaster zum Verabreichen von Fentanyl |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US27683701P | 2001-03-16 | 2001-03-16 | |
EP02715112A EP1381352B1 (de) | 2001-03-16 | 2002-03-15 | Transdermales pflaster zur verabreichung von fentanyl |
DE20221247U DE20221247U1 (de) | 2001-03-16 | 2002-03-15 | Transdermal-Pflaster zum Verabreichen von Fentanyl |
Publications (1)
Publication Number | Publication Date |
---|---|
DE20221247U1 true DE20221247U1 (de) | 2005-09-15 |
Family
ID=34276720
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE20221397U Expired - Lifetime DE20221397U1 (de) | 2001-03-16 | 2002-03-15 | Transdermal-Pflaster zum Verabreichen von Fentanyl |
DE20221247U Expired - Lifetime DE20221247U1 (de) | 2001-03-16 | 2002-03-15 | Transdermal-Pflaster zum Verabreichen von Fentanyl |
DE20220982U Ceased DE20220982U1 (de) | 2001-03-16 | 2002-03-15 | Transdermal-Pflaster zum Verabreichen von Fentanyl |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE20221397U Expired - Lifetime DE20221397U1 (de) | 2001-03-16 | 2002-03-15 | Transdermal-Pflaster zum Verabreichen von Fentanyl |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE20220982U Ceased DE20220982U1 (de) | 2001-03-16 | 2002-03-15 | Transdermal-Pflaster zum Verabreichen von Fentanyl |
Country Status (2)
Country | Link |
---|---|
EP (2) | EP1757280A1 (de) |
DE (3) | DE20221397U1 (de) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10141650C1 (de) | 2001-08-24 | 2002-11-28 | Lohmann Therapie Syst Lts | Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen |
CA2646206A1 (en) * | 2006-04-21 | 2007-11-01 | Labtec Gesellschaft Fuer Technologische Forschung Und Entwicklung Mbh | Transdermal delivery system comprising sufentanil and its analogues |
DE102011100619A1 (de) | 2010-05-05 | 2012-01-05 | Amw Gmbh | Transdermales therapeutisches System (TTS) mit einem Gehalt an einem Opiod-Analgetikum |
FR2992325B1 (fr) | 2012-06-26 | 2015-05-22 | Ab7 Innovation | Matrice sequencee multifonctionnelle monopolymerique en polyurethane coule et procede de fabrication |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4291015A (en) | 1979-08-14 | 1981-09-22 | Key Pharmaceuticals, Inc. | Polymeric diffusion matrix containing a vasodilator |
US5310559A (en) | 1982-09-01 | 1994-05-10 | Hercon Laboratories Corporation | Device for controlled release and delivery to mammalian tissue of pharmacologically active agents incorporating a rate controlling member which comprises an alkylene-alkyl acrylate copolymer |
US4588580B2 (en) | 1984-07-23 | 1999-02-16 | Alaz Corp | Transdermal administration of fentanyl and device therefor |
US4626539A (en) | 1984-08-10 | 1986-12-02 | E. I. Dupont De Nemours And Company | Trandermal delivery of opioids |
US5006342A (en) | 1986-12-22 | 1991-04-09 | Cygnus Corporation | Resilient transdermal drug delivery device |
US5186939A (en) | 1987-04-23 | 1993-02-16 | Cygnus Therapeutic Systems | Laminated composite for transdermal administration of fentanyl |
US5656286A (en) | 1988-03-04 | 1997-08-12 | Noven Pharmaceuticals, Inc. | Solubility parameter based drug delivery system and method for altering drug saturation concentration |
US5474783A (en) | 1988-03-04 | 1995-12-12 | Noven Pharmaceuticals, Inc. | Solubility parameter based drug delivery system and method for altering drug saturation concentration |
DE4310012A1 (de) * | 1993-03-27 | 1994-09-29 | Roehm Gmbh | Dermales therapeutisches System aus einer schmelzfähigen Poly(meth)acrylat-Mischung |
US5762952A (en) | 1993-04-27 | 1998-06-09 | Hercon Laboratories Corporation | Transdermal delivery of active drugs |
AU702593B2 (en) * | 1994-09-14 | 1999-02-25 | Minnesota Mining And Manufacturing Company | Matrix for transdermal drug delivery |
US6093419A (en) * | 1995-06-07 | 2000-07-25 | Lectec Corporation | Compliance verification method and device in compulsory drug administration |
TW411277B (en) * | 1996-05-13 | 2000-11-11 | Hisamitsu Pharmaceutical Co | Percutaneous tape preparation containing fentanyl |
US5985317A (en) | 1996-09-06 | 1999-11-16 | Theratech, Inc. | Pressure sensitive adhesive matrix patches for transdermal delivery of salts of pharmaceutical agents |
DE19653605C2 (de) | 1996-12-20 | 2002-11-28 | Roehm Gmbh | Haft- und Bindemittel für dermale oder transdermale Therapiesysteme und dessen Verwendung zur Herstellung eines transdermalen Therapiesystems |
DE19653606A1 (de) | 1996-12-20 | 1998-06-25 | Roehm Gmbh | Haft- und Bindemittel aus (Meth)acrylatpolymer, organischer Säure und Weichmacher |
GB9714650D0 (en) * | 1997-07-11 | 1997-09-17 | Strakan Ltd | Block copolymer |
US5948433A (en) | 1997-08-21 | 1999-09-07 | Bertek, Inc. | Transdermal patch |
EP1117389A1 (de) * | 1998-09-08 | 2001-07-25 | TheraTech, Inc. | Verfahren zur herstellung von druckempfindlichen klebepflastern enthaltend hydrophyle wirkstoffsalze |
KR20010036685A (ko) * | 1999-10-11 | 2001-05-07 | 김윤 | 펜타닐을 함유하는 매트릭스형 경피투여제 |
WO2001064149A1 (en) * | 2000-02-29 | 2001-09-07 | Jie Zhang | Improved transdermal drug patch |
US20020119187A1 (en) * | 2000-09-29 | 2002-08-29 | Cantor Adam S. | Composition for the transdermal delivery of fentanyl |
-
2002
- 2002-03-15 EP EP06018433A patent/EP1757280A1/de not_active Withdrawn
- 2002-03-15 DE DE20221397U patent/DE20221397U1/de not_active Expired - Lifetime
- 2002-03-15 EP EP07010050A patent/EP1875898A3/de not_active Withdrawn
- 2002-03-15 DE DE20221247U patent/DE20221247U1/de not_active Expired - Lifetime
- 2002-03-15 DE DE20220982U patent/DE20220982U1/de not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
DE20220982U1 (de) | 2004-11-25 |
EP1875898A3 (de) | 2008-08-27 |
EP1875898A2 (de) | 2008-01-09 |
EP1757280A1 (de) | 2007-02-28 |
DE20221397U1 (de) | 2005-10-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1009393T3 (da) | Transdermalt, terapeutisk system med hæfteklæbende reservoirlag og bagsidelag, som er elastisk i én retning | |
ATE363900T1 (de) | Therapeutisches pflaster mit capsaicin-haltiger polysiloxan-matrix | |
DE59410103D1 (de) | Transdermales therapeutisches system mit galanthamin als wirksamen bestandteil | |
ATE366567T1 (de) | Transdermales therapeutisches system mit hochdispersem siliziumdioxid | |
DE50209364D1 (en) | Transdermales therapeutisches system mit fentanyl | |
TW200517156A (en) | Pretreatment method and system for enhancing transdermal drug delivery | |
TW570815B (en) | Transdermal therapeutic system (TTS) containing the active substance fentanyl | |
ATE396714T1 (de) | Transdermales therapeutisches system mit verbessertem langzeittragekomfort | |
NZ584190A (en) | Once-a-day replacement transdermal administration of fentanyl | |
DE20221247U1 (de) | Transdermal-Pflaster zum Verabreichen von Fentanyl | |
MXPA05008366A (es) | Sistema terapeutico transdermico adecuado para la aplicacion de calor para promover la penetracion de sustancias activas y el uso del mismo. | |
DE50100870D1 (de) | Transdermales therapeutisches system zur verabreichung von zaleplon | |
IL176802A0 (en) | Transdermal delivery device for dihydropyridine type calcium antagonists containing at least one fatty acid | |
DK0680319T3 (da) | Nitroglycerin-holdigt plaster, fremgangsmåde til dets fremstilling og anvendelse heraf. | |
NO982621L (no) | Overflate-stabilisert farmas°ytisk bearbeiding for anvendelse pÕ huden | |
DE20221161U1 (de) | Transdermales therapeutisches System mit Fentanyl bzw. verwandten Substanzen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R207 | Utility model specification |
Effective date: 20051020 |
|
R150 | Utility model maintained after payment of first maintenance fee after three years |
Effective date: 20051020 |
|
R165 | Request for cancellation or ruling filed | ||
R165 | Request for cancellation or ruling filed | ||
R151 | Utility model maintained after payment of second maintenance fee after six years |
Effective date: 20080531 |
|
R152 | Utility model maintained after payment of third maintenance fee after eight years |
Effective date: 20100427 |
|
R169 | Utility model cancelled in part |
Effective date: 20100410 |
|
R071 | Expiry of right |